Uroplakin gene expression by normal and neoplastic human urothelium

American Journal of Pathology

Volumn 153, Issue 6, 1998, Pages 1957-1967

  Lobban, E Dawn ^a   Smith, Barbara A ^a   Hall, Geoffrey D ^a   Harnden, Patricia ^a   Roberts, Paul ^a   Selby, Peter J ^a   Trejdosiewicz, Ludwik K ^a   Southgate, Jennifer ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; UNCLASSIFIED DRUG; UROPLAKIN;

ARTICLE; CELL DIFFERENTIATION; DNA SEQUENCE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT TUMOR; UROTHELIUM;

EID: 0031740919     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65709-4     Document Type: Article

References (33)

1. Hodges GM: The urinary system-bladder. In Biomedical Research Applications of Scanning Electron Microscopy. Edited by Hodges GM Hallowes RC. London, Academic Press, 1979, pp 307-353
2. Trejdosiewicz LK, Wilson PD, Hodges GM: Species cross-reactive membrane-associated urothelial differentiation antigen. J Natl Cancer Inst 1984, 72:355-366
3. Wu XR, Manabe M, Yu J, Sun TT: Large scale purification and immunolocalization of bovine uroplakins I, II, and III: molecular markers of urothelial differentiation. J Biol Chem 1990, 265:19170-19179
4. Wu XR, Lin JH, Walz T, Haner M, Yu J, Aebi U, Sun TT: Mammalian uroplakins a group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem 1994, 269:13716-13724
5. Yu J, Lin JH, Wu XR, Sun TT: Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol 1994, 125: 171-182
6. Wu XR, Sun TT: Molecular cloning of a 47 kd tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J Cell Sci 1993, 106:31-43
7. Lin JH, Wu XR, Kreibich G, Sun TT: Precursor sequence, processing, and urothelium-specific expression of a major 15-kd protein subunit of asymmetric unit membrane. J Biol Chem 1994, 269:1775-1784
8. Moll R, Wu XR, Lin JH, Sun TT: Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Physiol 1995, 147:1383-1397
9. Wu RL, Osman I, Wu XR, Lu ML, Zhang ZF, Liang FX, Hamza R, Scher H, Cordon-Cardo C, Sun TT: Uroplakin Il gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res 1998, 58:1291-1297
10. Southgate J, Hutton KA, Thomas DF, Trejdosiewicz LK: Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 1994, 71:583-594
11. Harnden P, Parkinson MC: Transitional cell carcinoma of the bladder: diagnosis and prognosis. Curr Diagn Pathol 1996, 3:109-121
12. Harnden P, Allam A, Joyce AD, Patel A, Selby P, Southgate J: Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease. Histopathology 1995, 27:169-174
13. Trejdosiewicz LK, Southgate J, Donald JA, Masters JR, Hepburn PJ, Hodges GM: Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization. J Urol 1985, 133:533-538
14. Masters JRW, Hepburn PJ, Walker L, Highman WJ, Trejdosiewicz LK, Povey S, Parkar M, Hill BT, Riddle PR, Franks LM: Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 1986, 46:3630-3636
15. Moll R, Achtstatter T, Becht E, Balcarova-Stander J, Ittensohn M, Franke WW: Cytokeratins in normal and malignant transitional epithelium maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Am J Pathol 1988, 132:123-144
16. Rieger KM, Little AF, Swart JM, Kastrinakis WV, Fitzgerald JM, Hess DT, Libertino JA, Summerhayes IC: Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer 1995, 72:683-690
17. Senior PV, Critchley DR, Beck F, Walker RA, Varley JM: The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: an in situ hybridization and immunocytochemical study Development 1988, 104:431-446
18. Ponte P, Ng SY, Engel J, Gunning P, Kedes L: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res 1984, 12:1687-1696
19. Southgate J, Trejdosiewicz LK: Immunolabelling of cells and tissues: approaches and pitfalls. Hum Reprod 1997, 12:1265-1275
20. Simmons DL: Cloning cell surface molecules by transient expression in mammalian cells. In Cellular Interactions in Development: A Practical Approach. Edited by Hartley DA. Oxford, IRL, 1994, pp 93-127
21. Booth C, Harnden P, Trejdosiewicz LK, Scriven S, Selby PJ, Southgate J: Stromal and vascular invasion in a human in vitro bladder cancer model. Lab Invest 1997, 76:843-857
22. Harnden P, Mahmood N, Southgate J: Transitional cell tumours revisited: Cytokeratin 20 expression redefines the transitional cell papilloma. Lancet 1998 (in press)
23. Kallin B, de Martin R, Etzold T, Sorrentino V, Philipson L: Cloning of a growth arrest-specific and transforming growth factor β-regulated gene, TI 1, from an epithelial cell line. Mol Cell Biol 1991, 11:5338-5345
24. Maecker HT, Todd SC, Levy S: The tetraspan superfamily: molecular facilitators. FASEB J 1997, 11:428-442
25. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC: KAl1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995, 268: 884-886
26. Radford KJ, Mallesch J, Hersey P: Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer 1995, 62:631-635
27. Radford KJ, Thorne RF, Hersey P: Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 1997, 158:3353-3358
28. Finch JL, Webb GC, Evdokiou A, Cowled PA: Chromosomal localization of the human urothelial "tetraspan" gene, UPK1B, to 3q13.3-q21 and detection of a Taql polymorphism. Genomics 1997, 40:501-503
29. Atkin NB, Baker MC: Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11. Cancer Genet Cytogenet 1985, 15:253-268
30. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG: Allelotype of human bladder cancer. Cancer Res 1994, 54:531-538
31. Richter J, Jiang F, Gorog JP, Sartorius G, Egenter C, Gasser TC, Moch H, Mihatsch MJ, Sauter G: Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997, 57:2860-2864
32. Southgate J, Harnden P, Selby PJ, Thomas DFM, Trejdosiewicz LK: Urothelial tissue regulation: unraveling the role of the stroma. Adv Exp Biol Med 1998 (in press)
33. Baskin LS, Sutherland RS, Thomson AA, Nguyen HT, Morgan DM, Hayward SW, Hom YK, DiSandro M, Cunha GR: Growth factors in bladder wound healing. J Urol 1997, 157:2388-2395